X

Vijaya Diagnostics Q2 FY26 Earnings Results

Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine, radiology, laboratory, health check-ups and medical services. The company provides its services across 13 cities through its 81 diagnostic centers and 11 reference laboratories.

 

Q2 FY26 Earnings Results:

  • Consolidated Revenue: ₹201.56 crore, up 10.17% YoY and 7.18% QoQ.

  • Profit After Tax (PAT): ₹43.28 crore, up 2.75% YoY and 12.15% QoQ.

  • EBITDA: ₹81.83 crore, margin at 40.6%.

  • Employee costs increased to ₹32.26 crore from ₹31.61 crore QoQ.

  • Depreciation costs: ₹22.27 crore, up QoQ.

  • Interest costs: ₹7.83 crore, slightly higher QoQ.

  • Strong operational cash flow with ₹224 crore cash flow from operations in FY25.

  • Continued capital expenditure focus on new centres and equipment upgrades.

  • Commissioned new hub centres in Kasba, Kolkata; Nandyal, AP; Khammam, Telangana; and a new spoke in Alwal, Hyderabad.

  • Merger of Medinova Diagnostic Services Ltd with Vijaya approved by NCLT effective April 1, 2024.

  • Future expansions planned with two more hubs in West Bengal and a flagship centre at Bannerghatta, Bengaluru.

 

Management Commentary & Strategic Insights:

  • MD & CEO Suprita Reddy expressed confidence in sustained growth driven by volume increases, operational efficiencies, and regional expansion.

  • Rapid break-even achieved in new hubs, indicating strong market demand.

  • Significant focus on integrated diagnostics and application of advanced technologies such as PET-CT.

  • The company is strategically positioned to capitalize on growing demand in key markets including Bengaluru and West Bengal.

  • Maintaining disciplined cost management amid growth investments.

 

 

Q1 FY26 Earnings Results:

  • Revenue: ₹188.05 crore, up 20.5% YoY.

  • PAT: ₹38.59 crore, up 23.1% YoY.

  • EBITDA: ₹73.5 crore, margin at 39.1%.

  • Average realization per test and per footfall improved YoY.

  • Successful operation of new hubs in Pune, Bengaluru and West Bengal.

 

To view the company’s previous earnings and latest concall transcripts, click here  to visit the Alphastreet India news channel.

Tags: Diagnostics
Related Post